PetMed Express (NASDAQ:PETS) issued its quarterly earnings results on Sunday. The company reported $0.34 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.40 by ($0.06), MarketWatch Earnings reports. PetMed Express had a return on equity of 22.79% and a net margin of 9.82%. The business had revenue of $71.70 million for the quarter, compared to analysts’ expectations of $74.04 million. During the same quarter last year, the company earned $0.35 earnings per share. The firm’s revenue for the quarter was down 3.5% on a year-over-year basis.
PETS traded down $0.33 on Tuesday, reaching $29.15. The company’s stock had a trading volume of 15,063 shares, compared to its average volume of 759,308. The stock has a 50 day moving average of $32.75 and a two-hundred day moving average of $32.72. The company has a market capitalization of $590.90 million, a price-to-earnings ratio of 19.65 and a beta of 0.70. PetMed Express has a fifty-two week low of $27.60 and a fifty-two week high of $57.00.
The firm also recently declared a quarterly dividend, which will be paid on Friday, May 21st. Investors of record on Friday, May 14th will be issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 4.12%. This is an increase from PetMed Express’s previous quarterly dividend of $0.28. The ex-dividend date is Thursday, May 13th.
About PetMed Express
PetMed Express, Inc, together with its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, and other health products for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventative, flea and tick preventative, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.
Recommended Story: Pattern Day Trader – What is the PDT Rule?
Receive News & Ratings for PetMed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express and related companies with MarketBeat.com's FREE daily email newsletter.